STAT8h
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
STAT8h
With little fanfare, Biden administration stacked vaccine advisory committee with new members
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
An Unprecedented 22 Percent Drop in Drug Deaths Does Not Mean Prohibition Is Finally Working
During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Walmart's Broccoli Recall Now Classified as Potentially Deadly, According to the FDA
In early January it was revealed that Walmart's washed and ready-to-eat 12 oz. Marketside Broccoli Florets were voluntarily ...
The FDA Issued a Class I Recall on Ready-to-Eat Broccoli Across 20 States
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
New type of non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Bird Flu Studies Delayed as White House Halts CDC Reports
As a bird flu outbreak escalates across the U.S., the Trump administration has paused the release of key public health ...